MASLD Trial Patient Recruitment

How We Recruit MASLD Patients

Finding patients who don't know the acronym — but know the risk.

MASLD (metabolic dysfunction-associated steatotic liver disease, formerly NAFLD) is one of the most under-diagnosed conditions in the country: an estimated 80–100 million Americans have it, and most have never been told. Patients don't search for "MASLD" — they search for fatty liver, high liver enzymes, or metabolic syndrome. Our Meta (Facebook and Instagram) campaigns speak that language, then use a pre-screening lead form to identify patients who match your protocol's specific criteria before any lead reaches your team.

Our MASLD campaign in the Dallas–Fort Worth region delivered 442 pre-qualified leads on $1,236.88 in ad spend — $2.80 per lead. That volume demonstrates just how large and reachable this patient population is when the recruitment approach matches how patients actually think about their health.

• Plain-language creative targeting patients with fatty liver, metabolic syndrome, or elevated liver enzymes
• Pre-screening questions aligned to your protocol (liver stiffness thresholds, metabolic risk factors, prior imaging)
• IRB-ready ad creative and landing pages packaged for your submission